U.S. flag

An official website of the United States government

NM_024301.5(FKRP):c.809G>A (p.Arg270His) AND Autosomal recessive limb-girdle muscular dystrophy type 2I

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 1, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001830242.1

Allele description [Variation Report for NM_024301.5(FKRP):c.809G>A (p.Arg270His)]

NM_024301.5(FKRP):c.809G>A (p.Arg270His)

Gene:
FKRP:fukutin related protein [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.32
Genomic location:
Preferred name:
NM_024301.5(FKRP):c.809G>A (p.Arg270His)
HGVS:
  • NC_000019.10:g.46756259G>A
  • NG_008898.2:g.15214G>A
  • NM_001039885.3:c.809G>A
  • NM_024301.5:c.809G>AMANE SELECT
  • NP_001034974.1:p.Arg270His
  • NP_077277.1:p.Arg270His
  • LRG_761t1:c.809G>A
  • LRG_761:g.15214G>A
  • LRG_761p1:p.Arg270His
  • NC_000019.9:g.47259516G>A
Protein change:
R270H
Links:
dbSNP: rs1025118379
NCBI 1000 Genomes Browser:
rs1025118379
Molecular consequence:
  • NM_001039885.3:c.809G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_024301.5:c.809G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Autosomal recessive limb-girdle muscular dystrophy type 2I
Synonyms:
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, FRKP-RELATED; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0011787; MedGen: C1846672; Orphanet: 34515; OMIM: 607155

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002091319Natera, Inc.
no assertion criteria provided
Uncertain significance
(Mar 1, 2021)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002091319.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024